<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">32566334</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2090-6668</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>2020</Volume>
            <PubDate>
              <Year>2020</Year>
            </PubDate>
          </JournalIssue>
          <Title>Case reports in neurological medicine</Title>
          <ISOAbbreviation>Case Rep Neurol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Anti-NMDAR-Positive Small-Cell Lung Cancer Paraneoplastic Limbic Encephalitis: A Case Report and Literature Review.</ArticleTitle>
        <Pagination>
          <StartPage>5269352</StartPage>
          <MedlinePgn>5269352</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">5269352</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/5269352</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Paraneoplastic limbic encephalitis (PLE) is a rare disease that presents as rapid onset dementia characterized by short-term memory loss (STM), anxiety, and behavioral changes. Anti-NMDAR antibodies are unfrequently reported in PLE associated with small-cell lung cancer (SCLC). Given that PLE can precede the diagnosis of cancer, it is very important that once infectious, metabolic, nutritional, or structural disorders associated with short-term memory loss are ruled out that vigorous effort must be made to rule out underlying malignancy.</AbstractText>
          <AbstractText Label="CASE" NlmCategory="METHODS">We report a rare case of PLE as the presenting symptom of SCLC. A 72-year-old male with history of COPD was brought to the ED by his wife after he was found to have short-term memory loss, including forgetfulness of his wedding anniversary the day before, and anxiety. Neurological exam showed impaired short-term recall on MOCA. CT head showed no evidence of infarct. Lumbar puncture was performed which showed lymphocytic pleocytosis, a nonspecific inflammatory change. CSF panel was negative for HSV, <i>Neisseria</i>, <i>Hemophilus</i>, <i>E. coli</i>, and HIV. Initial EEG was unremarkable, though a repeat EEG showed mild slowing of the posterior dominant rhythm consistent with mild encephalopathy. MRI showed equivocal increased FLAIR on T2-weighted images in the bilateral temporal lobes, left greater than right. CTA thorax showed bulky mediastinal and right hilar LAD. FNA of the R4 lymph node revealed SCLC. The NM bone scan showed no osteoblastic lesions. While the serum autoantibody panel was positive for anti-NMDAR, the CSF autoantibody panel returned entirely negative. Chemotherapy with etoposide and cisplatin was started on Day 4 of admission. The patient's neurological symptoms showed improvement following chemotherapy.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This case highlights the importance of recognizing short-term memory loss as a feature of PLE.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Raman Sohal et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sohal</LastName>
            <ForeName>Raman</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-6792-4943</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adams</LastName>
            <ForeName>Steven H</ForeName>
            <Initials>SH</Initials>
            <Identifier Source="ORCID">0000-0001-7274-7590</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Phogat</LastName>
            <ForeName>Vishal</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harish</LastName>
            <ForeName>Abha</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lopez</LastName>
            <ForeName>Carlos Ynigo D</ForeName>
            <Initials>CYD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>Michael P A</ForeName>
            <Initials>MPA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khurana</LastName>
            <ForeName>Kamal K</ForeName>
            <Initials>KK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abuzuaiter</LastName>
            <ForeName>Basel</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jagroop</LastName>
            <ForeName>Nia</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Narapureddy</LastName>
            <ForeName>Bhavya</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>06</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Case Rep Neurol Med</MedlineTA>
        <NlmUniqueID>101576451</NlmUniqueID>
        <ISSNLinking>2090-6676</ISSNLinking>
      </MedlineJournalInfo>
      <CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32566334</ArticleId>
        <ArticleId IdType="pmc">PMC7288224</ArticleId>
        <ArticleId IdType="doi">10.1155/2020/5269352</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation> I. W. Altabakhi, H. M. Babiker, Paraneoplastic limbic encephalitis-StatPearls-NCBI bookshelf,  https://www.ncbi.nlm.nih.gov/books/NBK519523/</Citation>
        </Reference>
        <Reference>
          <Citation>Senties-Madrid H., Vega-Boada F. Paraneoplastic syndromes associated with anti-Hu antibodies. The Israel Medical Association Journal : IMAJ. 2001;3(2):94–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11344832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braverman J. A., Marcus C., Garg R. Anti-NMDA-receptor encephalitis: a neuropsychiatric syndrome associated with ovarian teratoma. Gynecologic Oncology Reports. 2015;14:1–3. doi: 10.1016/j.gore.2015.07.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gore.2015.07.004</ArticleId>
            <ArticleId IdType="pmc">PMC4688824</ArticleId>
            <ArticleId IdType="pubmed">26793760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gultekin S. H., et al.  Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(7):1481–1494. doi: 10.1093/brain/123.7.1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/123.7.1481</ArticleId>
            <ArticleId IdType="pubmed">10869059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ganesh A., Wesley S. F. Practice Current: when do you suspect autoimmune encephalitis and what is the role of antibody testing? Neurology: Clinical Practice. 2018;8(1):67–73. doi: 10.1212/cpj.0000000000000423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/cpj.0000000000000423</ArticleId>
            <ArticleId IdType="pmc">PMC5839684</ArticleId>
            <ArticleId IdType="pubmed">29517071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graus F., Titulaer M. J., Balu R., et al.  A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016;15(4):391–404. doi: 10.1016/s1474-4422(15)00401-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1474-4422(15)00401-9</ArticleId>
            <ArticleId IdType="pmc">PMC5066574</ArticleId>
            <ArticleId IdType="pubmed">26906964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalmau J., Gleichman A. J., Hughes E. G., et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet Neurology. 2008;7(12):1091–1098. doi: 10.1016/s1474-4422(08)70224-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1474-4422(08)70224-2</ArticleId>
            <ArticleId IdType="pmc">PMC2607118</ArticleId>
            <ArticleId IdType="pubmed">18851928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S. K., Lee S.-T. The laboratory diagnosis of autoimmune encephalitis. Journal of Epilepsy Research. 2016;6(2):45–50. doi: 10.14581/jer.16010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14581/jer.16010</ArticleId>
            <ArticleId IdType="pmc">PMC5206099</ArticleId>
            <ArticleId IdType="pubmed">28101474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boangher S., Mespouille P., Filip C.-M., Goffette S. Small-cell lung cancer with positive anti-NMDAR and anti-AMPAR antibodies paraneoplastic limbic encephalitis. Case Reports in Neurological Medicine. 2016;2016:3. doi: 10.1155/2016/3263718.3263718</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/3263718</ArticleId>
            <ArticleId IdType="pmc">PMC5187489</ArticleId>
            <ArticleId IdType="pubmed">28070431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen K., Xu Y., Guan H., et al.  Paraneoplastic limbic encephalitis associated with lung cancer. Scientific Reports. 2018;8(1) doi: 10.1038/s41598-018-25294-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-25294-y</ArticleId>
            <ArticleId IdType="pmc">PMC5931551</ArticleId>
            <ArticleId IdType="pubmed">29717222</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
